Abstract. The contribution of fasting and postprandial glucose to hemoglobin A 1c (HbA 1c ) levels was evaluated in insulin-treated patients. In 57 insulin-treated, diabetic out-patients, fasting glucose (before breakfast (B-FG), lunch (L-FG) and dinner (D-FG)) and postprandial glucose (B-PPG, L-PPG and D-PPG) levels were determined by the patients themselves at home using glucose self-monitoring apparatus over the course of one week. The correlation between HbA 1c levels and self monitored blood glucose levels were calculated. In the conventionally treated group, there was a significant correlation between HbA 1c and fasting glucose (FG) levels only before lunch, but at 2 hr after (PPG) all meals. In the intensively treated group, a significant correlation between HbA 1c levels and FG levels was found before lunch and at 2 hr after breakfast and dinner. In all subjects, only FG levels before lunch correlated significantly with HbA 1c levels, although PPG levels were significantly correlated with HbA 1c at all points. The correlation was highest with PPG after breakfast and dinner. The sum of all FG, PPG and FG + PPG levels was significantly correlated with HbA 1c levels. Postprandial hyperglycemia after breakfast and dinner should be regarded as most important for improving HbA 1c levels in insulin treated diabetic patients.
GLYCEMIC control is important in the prevention of diabetic complications in type 1 and type 2 diabetic patients [1, 2] . Hemoglobin A 1c (HbA 1c ) level is widely used as a marker of glycemic control. However, the relation of HbA 1c levels to diurnal excursion of blood glucose levels still remains to be clearly elucidated in diabetic subjects, since the relative contribution of postprandial glucose levels might be influenced by circumstances and subjects [3] . HbA 1c levels correlated more strongly with fasting plasma glucose levels than with the overall postprandial glucose exposure measured by a standardized meal test in newly diagnosed treatment-naïve subjects with type 2 diabetes mellitus [4] . The relative contribution of postprandial glucose levels decreased progressively from the lowest to the highest quintile of HbA 1c levels, whereas the relative contribution of fasting glucose levels increased gradually with increasing levels of HbA 1c in non-insulinand non-acarbose-treated diabetic subjects [5, 6] . While the HbA 1c level was more closely related to postprandial glucose levels in non-insulin-treated type 2 diabetic subjects [4] , the exact contribution of fasting and postprandial glucose to HbA 1c levels remains unclear in insulin-treated patients. We analyzed the contribution of diurnal glycemic profiles to HbA 1c levels in diabetic patients treated with insulin.
Fifty-seven insulin-treated, diabetic out-patients were recruited for this study. The number of patients treated with insulin twice a day (b.i.d.) was 24 (type 1 diabetes; 1, type 2 diabetes; 23), and the number intensively treated (basal-bolus) was 33 (type 1 diabetes; 14, type 2 diabetes; 19). Eligibility for the study was based on a diagnosis of diabetes for at least 12 months. In these patients, changes of the insulin dose used were maintained within 10% of total daily insulin dosage for at least 8 weeks before the start of the study. Diet and life-style were also not changed within the 3 months before the study. Fasting glucose (before breakfast (B-FG), lunch (L-FG) and dinner (D-FG)) and postprandial glucose (B-PPG, L-PPG and D-PPG) levels were measured by the patients themselves at home using glucose self-monitoring apparatus over the week before their visit to our hospital. HbA 1c levels were measured by HPLC on the visit to our hospital. The correlation of HbA 1c levels to self monitored blood glucose levels was calculated for each measurement point and the sum of blood glucose levels and the strengths of the relationships are given by coefficients of determination (γ 2 ).
The average HbA 1c levels in all subjects was 7.83%. In the patients treated with conventional insulin administration (b.i.d.), L-FG and all PPG levels correlated significantly with HbA 1c levels and the correlations We analyzed the correlation between blood glucose and HbA 1c levels in all patients included in the study (Fig. 1a) . There was no significant correlation between HbA 1c levels and B-FG or D-FG levels and only L-FG levels were significantly correlated with HbA 1c levels (γ = 0.513, p<0.001). In contrast, all PPG levels were significantly correlated with HbA 1c levels (B-PPG; γ = 0.576, p<0.001), L-PPG; (γ = 0.386, p<0.05) and D-PPG; γ = 0.650, p<0.001) and the correlation with D-PPG was highest. The sum of all FG and PPG levels was calculated (Fig. 1b) . The correlation of the sum of all PPG (B-PPG, L-PPG, D-PPG) levels to HbA 1c levels (γ = 0.641, p<0.001) was higher than the correlation of the sum of all FG levels (B-FG, L-FG, D-FG) to HbA 1c levels (γ = 0.485, p<0.05). The total of all FG and PPG levels was also significantly correlated with HbA 1c levels (γ = 0.624, p<0.001). Furthermore, we divided all patients into two groups (HbA 1c >7.5% and ≤7.5%) to examine the contribution of blood glucose to HbA 1c levels. In the group with HbA 1c ≤7.5%, there was no significant correlation between HbA 1c and blood glucose level at each point. In contrast, a significant correlation was found between HbA 1c and B-PPG (γ = 0.508, p<0.01) and D-PPG (γ = 0.541, p<0.01) in the group with HbA 1c >7.5%. We also examined the difference in the contribution between the types of diabetes. In type 1 diabetic patients (n = 15), all PPG levels correlated significantly with HbA 1c , while there was no correlation with FG levels at all. In type 2 diabetic patients (n = 42), B-FG, B-PPG, L-FG and D-PPG were all significantly correlated with HbA 1c .
The finding that both B-PPG and D-PPG levels are highly correlated with HbA 1c levels in insulin-treated, diabetic out-patients, especially poorly-controlled patients, but only L-FG glucose levels correlated significantly with HbA 1c levels, indicate that PPG levels should be considered a more important determinant of HbA 1c levels than FG levels in insulin-treated diabetic patients, and that blood glucose excursion in the morning could be an important determinant of HbA 1c levels in both type 1 and type 2 diabetic patients treated with insulin. Fasting glucose level is an important factor, which determines HbA 1c levels in newly diagnosed, treatment-naïve, type 2 diabetic patients [4] . However postprandial glucose levels appear to contribute to HbA 1c levels in diabetic patients treated with sulfonylurea or by diet alone who show fairly good glycemic control [5, 6] . The present data raise the possibility that PPG could contribute more to HbA 1c levels than FG in insulin-treated diabetic patients. Reduction of postprandial hyperglycemia by the addition of a fastacting insulin component has been shown to be beneficial to the improvement of HbA 1c levels in type 2 diabetes [7, 8] . It is suggested that improvement of PPG levels should be indispensable in normalizing HbA 1c levels in diabetic patients treated with insulin. 
